The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and antianxiety medications in adolescents and young adults has increased sharply since 2001, according to Rutgers Health ...
Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, ...
Brain exercises can have a powerful way of maintaining cognition and reducing the risk of dementia Read ahead to know how!
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), a pharmaceutical company with a market capitalization of ...
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...
Hosted on MSN23h
Study reveals potential drug links to Dementia riskBy Dr. Chinta Sidharthan Analysis of millions of patient records suggests potential benefits from antimicrobials and harms ...
Weight loss doesn’t equate to better health, alcohol is good in moderation – this professor is turning health rules on their heads ...
Verywell Health on MSN15h
Why It's Hard for Patients to Get the Newest Alzheimer's DrugsAccess to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion centers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback